Rifampin Capsule — FDA Drug Shortage

Current — Lupin Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Rifampin Capsule (capsule) from Lupin Pharmaceuticals, Inc. with status Current. The shortage was first posted on Dec 22, 2021.

Shortage details

Status
Current
Company
Lupin Pharmaceuticals, Inc.
Package NDC
68180-658-06
Dosage Form
Capsule
Presentation
Rifampin, Capsule, 150 mg (NDC 68180-658-06)
Initial Posting
Dec 22, 2021

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.